Fortive director exercises options, sells 7,131 shares

Fortive director Kate Mitchell reported several equity transactions involving company stock.

Rhea-AI Filing Summary

Fortive director Kate Mitchell reported several equity transactions involving company stock. On February 18, 2026, she exercised a Director Stock Option for 7,131 shares at an exercise price of $29.58 per share, converting a derivative award into common stock. The filing then shows she sold 7,131 shares of common stock in an open-market transaction at a weighted average price of about $58.34 per share, leaving 31,775 common shares held directly after the sale. An additional 4,260 common shares are reported as held indirectly in a living trust. Footnotes explain that both the stock options and restricted stock units reflect anti-dilution adjustments related to the spin-off of Ralliant Corporation and that the sale price represents a weighted average across multiple trades.

Insider Trade Summary

Exercise and Sale: 7,131 shares ($205K approx. pre-tax spread)

Exercise and Sale 4 txns

Insider MITCHELL KATE

Role Director

Sold 7,131 shs ($416K)

Approx. gross sale proceeds $416K

Approx. exercise cost $211K

Approx. pre-tax spread $205K

Type	Security	Shares	Price	Value
Exercise	Director Stock Option (Right to Buy)	7,131	$0.00	$0.00
Exercise	Common Stock	7,131	$29.58	$211K
Sale	Common Stock	7,131	$58.34	$416K
holding	Common Stock	--	--	--

Holdings After Transaction: Director Stock Option (Right to Buy) — 0 contracts (Direct); Common Stock — 31,775 shares (Direct); Common Stock — 4,260 shares (Indirect, Held in Living Trust)

Footnotes (3)

1. F1. In connection with the spin-off of Ralliant Corporation by the Issuer, outstanding Restricted Stock Units ("RSUs"), including RSUs previously granted to the Reporting Person, were subject to anti-dilution adjustments ("Anti-Dilution Adjustment"). To the extent that the outstanding RSUs granted to the Reporting Person were previously reported under Table I, the total number of shares reported include the additional RSUs held by the Reporting Person as a result of the Anti-Dilution Adjustment.
2. F2. The price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.330 to $58.351. The Reporting Person undertakes to provide to the Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
3. F3. The Director Stock Options reported herein, including the number of options and the exercise price, reflect the Anti-Dilution Adjustment.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Fortive (FTV) director Kate Mitchell report in this Form 4?

Kate Mitchell reported exercising a director stock option for 7,131 Fortive shares at an exercise price of $29.58 per share, then selling 7,131 common shares at a weighted average price of about $58.34 per share, and updating her direct and indirect share holdings.

How many Fortive (FTV) shares did Kate Mitchell sell and at what price?

Kate Mitchell sold 7,131 shares of Fortive common stock in an open-market transaction. The filing reports a weighted average sale price of approximately $58.34 per share, with individual trades executed between $58.330 and $58.351 according to the footnote disclosure.

What option exercise did Kate Mitchell report for Fortive (FTV)?

She reported exercising a Director Stock Option for 7,131 Fortive shares. The exercise converted a derivative security into common stock at an exercise price of $29.58 per share, and the options themselves reflect anti-dilution adjustments tied to the spin-off of Ralliant Corporation.

How many Fortive (FTV) shares does Kate Mitchell hold after these transactions?

After the reported transactions, Kate Mitchell holds 31,775 Fortive common shares directly. The Form 4 also shows 4,260 additional common shares held indirectly in a living trust, indicating a separate ownership line associated with her beneficial interests.

What do the anti-dilution adjustments mentioned in the Fortive (FTV) Form 4 mean?

The filing states that outstanding restricted stock units and director stock options, including those held by Kate Mitchell, were adjusted for an anti-dilution mechanism related to the spin-off of Ralliant Corporation, increasing the number of units and options to reflect the corporate action’s impact.

How is the sale price range for Kate Mitchell’s Fortive (FTV) stock described?

The Form 4 explains that the reported price is a weighted average for multiple trades. Individual sales occurred between $58.330 and $58.351 per share, and Mitchell undertakes to provide detailed breakdowns of shares sold at each separate price upon request.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/19/2026 - 05:12 PM EST Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

MITCHELL KATE

(Last) (First) (Middle)

6920 SEAWAY BLVD

(Street)

EVERETT WA 98203

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Fortive Corp [ FTV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/18/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/18/2026		M		7,131	A	$29.58	38,906(1)	D
Common Stock	02/18/2026		S		7,131	D	$58.34(2)	31,775(1)	D
Common Stock								4,260	I	Held in Living Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Director Stock Option (Right to Buy)(3)	$29.58	02/18/2026		M			7,131	07/05/2016	07/05/2026	Common Stock	7,131	$0	0	D

Explanation of Responses:

1. In connection with the spin-off of Ralliant Corporation by the Issuer, outstanding Restricted Stock Units ("RSUs"), including RSUs previously granted to the Reporting Person, were subject to anti-dilution adjustments ("Anti-Dilution Adjustment"). To the extent that the outstanding RSUs granted to the Reporting Person were previously reported under Table I, the total number of shares reported include the additional RSUs held by the Reporting Person as a result of the Anti-Dilution Adjustment.

2. The price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.330 to $58.351. The Reporting Person undertakes to provide to the Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

3. The Director Stock Options reported herein, including the number of options and the exercise price, reflect the Anti-Dilution Adjustment.

Remarks:

	Daniel B. Kim, as attorney-in-fact	02/19/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.